XML 58 R44.htm IDEA: XBRL DOCUMENT v3.6.0.2
CAPITALIZED FEES PAID TO A RELATED PARTY (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2016
Dec. 31, 2015
Dec. 31, 2014
Capitalized Fees paid to a Related Party      
Capitalized fees paid to a related party, useful life 15 years    
Net carrying value $ 180,545 $ 194,368  
Weighted average remaining amortization period 13 years 1 month 6 days    
Amortization expense $ 13,823 13,823 $ 11,066
Capitalized Fees paid to a Related Party, Future amortization      
Estimated amortization expense for the year 2017 13,800    
Estimated amortization expense for the year 2018 13,800    
Estimated amortization expense for the year 2019 13,800    
Estimated amortization expense for the year 2020 13,800    
Estimated amortization expense for the year 2021 13,800    
Estimated amortization expense thereafter 111,400    
GSK      
Capitalized Fees paid to a Related Party      
Gross carrying value 220,000 220,000  
Accumulated amortization (39,455) (25,632)  
Net carrying value 180,545 194,368  
GSK | United States      
Capitalized Fees paid to a Related Party      
Gross carrying value 120,000 120,000  
GSK | Europe      
Capitalized Fees paid to a Related Party      
Gross carrying value 60,000 60,000  
GSK | Japan      
Capitalized Fees paid to a Related Party      
Gross carrying value $ 40,000 $ 40,000